{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:10:03Z","timestamp":1784045403404,"version":"3.55.0"},"reference-count":32,"publisher":"Massachusetts Medical Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NEJM Catalyst"],"published-print":{"date-parts":[[2026,5,20]]},"DOI":"10.1056\/cat.25.0420","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:45:11Z","timestamp":1779281111000},"source":"Crossref","is-referenced-by-count":0,"title":["Impact of a Clinic- and Mail-Based Cervical Cancer Human Papillomavirus Self-Collect Screening Program"],"prefix":"10.1056","volume":"7","author":[{"given":"Beverly B.","family":"Green","sequence":"first","affiliation":[{"name":"Senior Investigator, Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA"},{"name":"Professor, Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Mogk","sequence":"additional","affiliation":[{"name":"Collaborative Scientist, Center for Accelerating Care Transformation, Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandi","family":"Crawford-Gallagher","sequence":"additional","affiliation":[{"name":"Research Interventionist, Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara C.","family":"Beatty","sequence":"additional","affiliation":[{"name":"Research Project Manager, Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyuan","family":"Gao","sequence":"additional","affiliation":[{"name":"Data Reporting and Analytics Consultant, Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa V.","family":"Piccorelli","sequence":"additional","affiliation":[{"name":"Senior Collaborative Biostatistician, Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley I.","family":"Shyn","sequence":"additional","affiliation":[{"name":"Medical Director, Population Health, Washington Permanente Medical Group, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula M.","family":"Lozano","sequence":"additional","affiliation":[{"name":"Senior Associate Medical Director for Research and Translation, and Codirector of the Center for Accelerating Care Transformation, Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70043"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.5888\/pcd22.250139"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25396"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6815a1"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.10897"},{"key":"e_1_3_3_7_2","unstructured":"Reynolds S. FDA approves HPV tests that allow for self-collection in a health care setting. July 24 2024 (https:\/\/www.cancer.gov\/news-events\/cancer-currents-blog\/2024\/fda-hpv-test-self-collection-health-care-setting)."},{"key":"e_1_3_3_8_2","unstructured":"Health Resources and Services Administration. Update to the women\u2019s preventive services guidelines. A Notice by the Health Resources and Services Administration. January 5 2026 (https:\/\/www.federalregister.gov\/documents\/2026\/01\/05\/2025-24235\/update-to-the-womens-preventive-services-guidelines)."},{"key":"e_1_3_3_9_2","unstructured":"Health Resources and Services Administration. Women\u2019s preventive services guidelines: new cervical cancer screening guidelines. Reviewed December 2025 (https:\/\/www.hrsa.gov\/womens-guidelines)."},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.Epi-25-0362"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(18)30763-0"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008587.pub2"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2026.1304"},{"key":"e_1_3_3_14_2","unstructured":"United States Preventive Services Task Force. Draft recommendation: cervical cancer: screening. December 10 2024 (https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/draft-recommendation\/cervical-cancer-screening-adults-adolescents)."},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.7004"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/lgt.0000000000000885"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/lgt.0000000000000530"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106900"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.14729"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.21471"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.34960"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/lrh2.10258"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2022.106960"},{"key":"e_1_3_3_24_2","unstructured":"Centers for Disease Control and Prevention. Clinical Laboratory Improvement Amendments (CLIA). Updated September 11 2024 (https:\/\/www.cdc.gov\/clia\/php\/about\/index.html)."},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/16094069241256275"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106896"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.10400"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2025.1590"},{"key":"e_1_3_3_29_2","unstructured":"Food and Drug Administration. Letter to Roche Molecular Systems Inc. Re: P100020\/S055 and P190028\/S009. May 14 2024 (https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf10\/P100020S055A.pdf)."},{"key":"e_1_3_3_30_2","unstructured":"Food and Drug Administration. Letter to Becton Dickinson and Company Re: P160037\/S017. May 14 2024 (https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf16\/P160037S017A.pdf)."},{"key":"e_1_3_3_31_2","unstructured":"Food and Drug Administration. Premarket approval (PMA): BD Onclarity HPV Assay. April 27 2026 (https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?id=P160037S024)."},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.62634"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-003743"}],"container-title":["NEJM Catalyst"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:55:32Z","timestamp":1784044532000},"score":1,"resource":{"primary":{"URL":"https:\/\/catalyst.nejm.org\/doi\/10.1056\/CAT.25.0420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,5,20]]}},"alternative-id":["10.1056\/CAT.25.0420"],"URL":"https:\/\/doi.org\/10.1056\/cat.25.0420","relation":{},"ISSN":["2642-0007"],"issn-type":[{"value":"2642-0007","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,20]]}}}